SulfachloropyridazineSodium Market by Patient Type (Cows, Pigs, Chickens, Cattles, andPediatrics), and by Region (North America, Europe, Asia Pacific, Latin America,Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018– 2026
Sulfachloropyridazine sodium is asulfonamide antibiotic used to study kinetics and reaction pathways. Also, itis used to treat acute Urinary Tract Infections (UTIs) in pediatric patients.Sulfachloropyridazine sodium blocks the synthesis of dihydrofolic acid byinhibiting the enzyme dihydropteroate synthase and bacterial Para-Amino BenzoicAcid (PABA), which is required for bacterial growth. The compoundSulfachloropyridazine sodium powder has a curative effect for various animalswith pasteurellosis and is popular for use in animal husbandry.
Sulfachloropyridazine SodiumMarket Drivers
Rising use of antibiotics inanimals to treat certain infections is expected to drive growth of thesulfachloropyridazine sodium market. For instance, according to an articlepublished in journal Science, 2017, almost 80% of all antibiotics in the U.S.are administered to cows, pigs, and chickens to keep them healthy and acceleratetheir growth and development.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2263
Moreover, according to theLouisiana Department of Health, U.S., due to low cost and relatively better efficacy against many common bacterialinfections, sulfonamides are some of the most common antibacterial agents utilized inveterinary medicine, which is in turn is boosting growth of the sulfachloropyridazinesodium market.
Sulfachloropyridazine SodiumMarket Restraint
Over the years, bacterialpathogens have acquired resistance to sulfonamide class of antibiotics, due tomutations in pre-existing DNA or by acquisition of Antibiotic Resistance Genes(ARGs), which is expected to hinder growth of the sulfachloropyridazine sodiummarket. For instance, according to an article published in journal Microbiome,2017, use of sulfonamide class of antibiotics is restricted to topical use onlyextensively for animals. For instance,in the U.S., around 380,186 kg of sulfonamides was distributed legally during2015, to increase the resistance power of food-producing animals. Hence,further spread of sulfonamide resistance would have hamper the market particularlyin the animal sector.
Sulfachloropyridazine SodiumMarket – Regional Analysis
On the basis of region, theglobal sulfachloropyridazine sodium market is segmented into North America,Latin America, Europe, Asia Pacific, Middle East, and Africa.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/sulfachloropyridazine-sodium-market-2263
North America region is expectedto gain maximum share in the sulfachloropyridazine sodium market, owing to highprevalence of Urinary Tract Infections (UTIs) in the U.S. For instance,according to American Urological Association 2016, more than 1 millioncatheter-associated UTIs are reported annually in the U.S. and up to 40% ofhospital gram negative bacteremias originate as UTIs annually, which aretreated by antibiotics.
Asia Pacific region is expectedto witness significant growth in the sulfachloropyridazine market due toinvolvement of key players in manufacturing antibiotics solely for veterinarypurposes. One of the company named Weifang Premier Animal PharmaceuticalIndustries Co., Ltd, a China-based company also involved in animal husbandry.They contributes to animal health by manufacturing sulfachloropyridazine sodiumsoluble powder as one of the key product in China.
Key players involved inSulfachloropyridazine market include Sigma-Aldrich, Inc., Zhengzhou FuyuanChemical Industry Co., Ltd, Santa Cruz Biotechnology, Inc., UBM, Hefei TNJChemical Industry Co., Ltd., AK Scientific Inc., SuZhou Wugan PharmaceuticalCo., Quimica Alkano, Shanghai Danfan Network Science&Technology Co., Ltd.,and Ofichem Group.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2263
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
